The Latest in Critical Care, 10/23/23 (Issue #17)
ACORN trial (cefepime vs. pip-tazo), Paxlovid for Omicron, MDROs on the rise
Keep reading with a 7-day free trial
Subscribe to PulmCCM to keep reading this post and get 7 days of free access to the full post archives.


